1,000 - half will receive the drug and half will receive placbo

Yes - folks are welcome to enroll anytime here:
longcovid.scripps.edu/locitt-t/?ut...

The webinar is completely optional.

Yes - please see this case series re: MCAS:
pubmed.ncbi.nlm.nih.gov/40675372/

And @kaufmanmd.bsky.social recent talk re: Long COVID and ME (he's also discussed this in other forums):
youtu.be/Cev3v-O82f0?...

The trial is now open to all US states except for Hawaii (due to shipping constraints); people in Washington DC and Puerto Rico are also eligible

We are using dosing that's FDA approved for other indications. MDs will work with each participant on individualized dosing plans.

Yes, and we'd love to do a follow-on pediatric trial if this one goes well

We are adding states when we can and if you sign up for the waitlist here, we'll let you know when your state ready:
mydatahelps.org/e/LOCITT/Wai...

So glad this line resonated with you ❤️‍🩹

Lots more background on this trial, including where the wonderful study team is coming from:

“When you are dealing with relentless, debilitating symptoms — each day matters. It can be the difference between experiencing life’s most meaningful events up close and seeing photos of them from afar.” 💔❤️

Good point - shared this with the team

Confirming we are actively working on NY!

There are findings about GLP-1RA’s benefits in so many diseases, including MCAS ( www.amjmedsci.com/article/S000... ).

I’m so thrilled we’re getting such a robust trial to see what one can do in Long Covid.